Galectin Therapeutics Inc.GALTNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank27
3Y CAGR-4.9%
5Y CAGR+0.8%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-4.9%/yr
vs -2.0%/yr prior
5Y CAGR
+0.8%/yr
Recent deceleration
Acceleration
-2.9pp
Decelerating
Percentile
P27
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$5.66M-2.8%
2024$5.83M-2.0%
2023$5.94M-9.7%
2022$6.58M+4.2%
2021$6.32M+16.3%
2020$5.43M-8.5%
2019$5.94M-16.8%
2018$7.13M+57.6%
2017$4.53M-26.5%
2016$6.16M-